Routine RTA confirmation certificate filing for Q2 FY27
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.9 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Prism Medico and Pharmacy has submitted a confirmation certificate from its Registrar and Share Transfer Agent, Purva Sharegistry, under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The RTA confirms that all dematerialisation requests received from depository participants during the quarter were processed within the required timelines, with no share certificates dematerialised during this period. This is a standard quarterly compliance filing.
Routine compliance filing with no material impact on shareholders or the stock. No dematerialisation activity reported this quarter.